About Okasa Pharma Private Limited
Data last updated:
Okasa Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the metals retail and distribution segment of the metals and mining sector. It was incorporated on 25 May 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1990PTC071153. Its GSTIN is 27AAACO0477A3ZT (Maharashtra). The company holds 10 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹10.5 Cr and a paid-up capital of ₹22 Lakh. It is led by directors Raman Parameswaran Athipotta and Srinivas Hariharan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 Gunbow Street Fort Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.97 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹23.01 Cr (net margin 92.2%) and EBITDA of ₹23.14 Cr (EBITDA margin 92.7%). Revenue has grown at a compounded annual rate (CAGR) of 106% over three years and 25% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹5.25 Cr on record. Court records list 26 cases involving the company, including 12 filed by the company and 14 filed against it; 4 cases are pending. The company has 2 deals on record (1 secondary share transfer, 1 acquisition); the latest was in January 2015. Its 10 peer companies in the Metals and Minerals industry (Metal Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Key Ispat Private Limited. with revenue of ₹25.16 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website okasa.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address12 Gunbow Street Fort Mumbai, Maharashtra, India – 400001
- IndustryMetals and Minerals, Metal Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Okasa Pharma Private Limited FY 2025 filings available
Okasa Pharma Private Limited reported revenue of ₹24.97 Cr (up 13855% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Okasa Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years. EBITDA rose 669% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Okasa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23.14 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹23.01 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Okasa Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 92.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 92.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Okasa Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Okasa Pharma Private Limited
Okasa Pharma Private Limited is compared with the companies closest to it by revenue in the Metals and Minerals industry (Metal Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Key Ispat Private Limited. | ₹25.16 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Delhi, India |
| Steelex India Pvt Ltd. | ₹25.08 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Kolkata, West Bengal, India |
| Sre Minings Private Limited | ₹25.05 Cr (FY 2024) | •••• | •••• | 765.0% | •••• | Tiruvannamalai, Tamil Nadu, India |
| R S Jhaveri Steels Private Limited | ₹25 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Shrinika Impex Private Limited | ₹24.99 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Bhilai, Chhattisgarh, India |
| Okasa Pharma Private Limited this company | ₹24.97 Cr (FY 2025) | •••• | •••• | 13855.0% | •••• | Mumbai, Maharashtra, India |
| K R Traders Pvt Ltd | ₹24.93 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Guwahati, Assam, India |
| Vardhman Plastics Pvt Ltd | ₹24.92 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | Kolkata, West Bengal, India |
| Silver Star Commotrade Pvt Ltd | ₹24.88 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Kolkata, West Bengal, India |
| Ambar Special Steel Private Limited | ₹24.79 Cr (FY 2024) | •••• | •••• | 151.0% | •••• | Nashik, Maharashtra, India |
| Blick System India Private Limited | ₹24.76 Cr (FY 2024) | •••• | •••• | 390.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Okasa Pharma by revenue in the Metals and Minerals industry (Metal Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Okasa Pharma Private Limited
Okasa Pharma Private Limited is audited by SHAHADE & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHAHADE & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Okasa Pharma Private Limited
Okasa Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raman Parameswaran Athipotta Also directs: Alps Remedies Private Limited | Director | 31 Jan 2015 | 11 Years 8 Months | Current |
| Srinivas Hariharan | Director | 04 Sep 2002 | 24 Years 1 Months | Current |
Ownership and Shareholding of Okasa Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Okasa Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2004 | Axis Bank Limited | ₹3.75 Cr | Satisfied |
| 04 Jan 1993 | The Saraswat Co Operative Bank Ltd | ₹1.5 Cr | Satisfied |
Total charge records: 2 View all charges
Deals & Funding of Okasa Pharma Private Limited
Okasa Pharma Private Limited has 2 deals on record (1 secondary share transfer, 1 acquisition); the latest was in January 2015.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2015 | Secondary share transfer | Undisclosed | Buyer: an individual |
| Sep 2014 | Acquisition | ₹71.98 Cr | Buyer: Medispray Laboratories Private Limited Seller: Okasa Pharma Private Limited |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Okasa Pharma Private Limited
Okasa Pharma Private Limited has 26 court cases on record: 12 filed by Okasa Pharma, 14 filed against it. 4 cases are pending and 22 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 25 | 13 | 4 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against National Pharmaceutical Pricing Authority and 3 Ors | Pending |
| Bombay High Court | Writ petition | Filed by the company against National Pharmaceutical Pricing Authority and 3 Ohters | Pending |
| Bombay High Court | Tax appeal | Filed against the company by Commissioner of Income Tax , Central I ,Mumbai | Pending |
| Bombay High Court | Court case (CHOL) | Filed by the company against National Pharmaceutical Pricing Authority and 3 Ors | Disposed |
| Bombay High Court | Writ petition | Filed by the company against National Pharmaceutical Pricing Authority | Disposed |
Full case history
All 26 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Okasa Pharma Private Limited
Okasa Pharma Private Limited has a workforce of 1 employees as of Apr 03, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Okasa Pharma Private Limited
Okasa Pharma Private Limited has 4 board changes on record since 2002: 2 appointments and 2 cessations. The latest: Raman Parameswaran Athipotta ceased to be Additional Director on 30 Sep 2015.
Credit Ratings, Litigation & Regulatory Alerts for Okasa Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Okasa Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Okasa Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Okasa Pharma Private Limited
Okasa Pharma has 10 GST registrations: 3 active and 7 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACO0477A3ZT | Maharashtra | Active | 16 Mar 2021 |
| 08AAACO0477A1ZV | Rajasthan | Active | 26 Mar 2021 |
| 24AAACO0477A1Z1 | Gujarat | Active | 19 May 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Okasa Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Okasa Pharma Private Limited
Okasa Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in metal retail and distribution, within the metals and minerals industry. It was incorporated on 25 May 1990 (36+ years old) and is registered under CIN U24239MH1990PTC071153.
Okasa Pharma reported revenue of ₹24.97 Cr for FY 2025 (up 13855% YoY).
Okasa Pharma has 2 current directors:
- Raman Parameswaran Athipotta - Director
- Srinivas Hariharan - Director
Okasa Pharma reported a net profit of ₹23.01 Cr (net margin 92.2%) and EBITDA of ₹23.14 Cr (EBITDA margin 92.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Okasa Pharma is 106% over three years and 25% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Okasa Pharma is 27AAACO0477A3ZT, registered in Maharashtra. The company has 10 GST registrations in all, of which 3 are active and 7 are cancelled or inactive. Other active GSTINs include 08AAACO0477A1ZV (Rajasthan), 24AAACO0477A1Z1 (Gujarat).
The CIN (Corporate Identification Number) of Okasa Pharma is U24239MH1990PTC071153. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Okasa Pharma has 26 court cases on record: 12 filed by the company and 14 filed against it. 4 are pending. Most are in the high courts.
Okasa Pharma was incorporated on 25 May 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.
Okasa Pharma has 2 deals on record (1 secondary share transfer, 1 acquisition); the latest was in January 2015.
The peers of Okasa Pharma by revenue are Key Ispat Private Limited, Steelex India Pvt Ltd, Sre Minings Private Limited, R S Jhaveri Steels Private Limited, Shrinika Impex Private Limited and 5 more, all in the Metals and Minerals industry (Metal Retail and Distribution).